Brief: Theranexus FY Operating Loss Widens To 7.0 Million Euros

Thx Pharma SA

17/04/2019 06:40

April 17 (Reuters) - THERANEXUS SA  ALTHX.PA :
    * FY OPERATING PRODUCT EUR 175,000 VERSUS EUR 164,000 YEAR
AGO
    * FY OPERATING LOSS EUR 7.0 MILLION VERSUS LOSS OF EUR 2.8
MILLION
YEAR AGO
    * FY NET LOSS EUR 5.3 MILLION VERSUS LOSS OF EUR 2.1 MILLION
YEAR
AGO
    * RESULTS ON THN102 EXPECTED IN Q2 2019
    * CASH POSITION AMOUNTED TO €15,170K AT 31 DECEMBER 2018 AND
€12,446K AT 31 MARCH 2019
    * RESULTS ON THN201 EXPECTED END 2019
    * RESULTS ON  THN101 EXPECTED BEFORE END OF H1 2019


Further company coverage:  ALTHX.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com;))